We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Haemonetics Corp (HAE) Com Stk USD

Sell:$85.43 Buy:$85.45 Change: $0.83 (0.98%)
Market closed |  Prices as at close on 21 November 2024 | Switch to live prices |
Sell:$85.43
Buy:$85.45
Change: $0.83 (0.98%)
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
Market closed |  Prices as at close on 21 November 2024 | Switch to live prices |
Sell:$85.43
Buy:$85.45
Change: $0.83 (0.98%)
Market closed |  Prices as at close on 21 November 2024 | Switch to live prices |
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Haemonetics Corporation is a global healthcare company. The Company is engaged in providing a suite of medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Its technology addresses various medical markets, including blood and plasma component collection, the surgical suite, and hospital transfusion services. The Company’s Plasma segment includes plasma collection devices and disposables, donor management software and supporting software solutions sold to plasma customers. Its Blood Center segment includes blood collection and processing devices and disposables for red cells, platelets and whole blood. The Company’s Hospital segment consists of Interventional Technologies, which includes vascular closure devices and sensor-guided technologies, and Blood Management Technologies, which includes devices and methodologies for measuring coagulation characteristics of blood, and blood transfusion management software, among others.

Contact details

Address:
125 Summer Street
BOSTON
02110
United States
Telephone:
+1 (781) 8487100
Website:
https://www.haemonetics.com

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
HAE
ISIN:
US4050241003
Market cap:
$4.27 billion
Shares in issue:
50.22 million
Sector:
Health Care Supplies
Exchange:
New York Stock Exchange
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • Christopher Simon
    President, Chief Executive Officer, Director
  • James D'arecca
    Executive Vice President, Chief Financial Officer
  • Roy Galvin
    President - Global Plasma and Blood Center
  • Stewart Strong
    President - Global Hospital
  • Laurie Miller
    Chief Human Resource Officer, Senior Vice President
  • Michelle Basil
    Executive Vice President, General Counsel
  • Josep Llorens
    Executive Vice President - Global Manufacturing and Supply Chain

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Options

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.